• Manufacturing

API & Intermediates Manufacturing

Commercial Plants

Anhui Ma’anshan c-GMP Manufacturing Site
  • Total Area:87,860 m2
  • Reactors numbers:110+
  • Total volume: ~310,000L
Ma’anshan, Anhui Province — ADC & HPAPI Manufacturing
  • 1500m2 HPAPI GMP kg scale plant in production since 2021
  • 2,900m2 under construction
  • Total volume : 3,000L
  • Tofflon separator (OEL <1μg/m3 ) covering in the full spectrum of HPAPI of pharma
  • SOP controlled exposure: Maximum HPAPI safety is achieved by negative pressure separators for weighing, process development, pre-lyophilization handling. End-to-end production management in controlled working area
  • Scheduled monitoring: Air dust detection and alarm system, continuous staff training (SOP for PPE, emergency response, etc)
Drug Product
Jiangsu GMP Manufacturing
  • 5 independent Class D manufacturing areas
  • Oral solid dosages: 4 workshops; annual manufacturing capacity: ~1 billion units
  • Semi solid topical dosages: 2 workshop; annual manufacturing capacity: ~ 40 million tubes
  • GMP warehouses of various storage conditions including cold storage
  • Formulation development and manufacturing capabilities include tablets, hard capsules, granules, powders, creams, ointment and gels, including anti-tumor drugs (OEB3/4)
Learn About Our Products

Online Message

Submitted successfully
3sClose the window